Clinton Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-24,516
| Closed | -$471K | – | 766 |
|
|
2017
Q1 | $471K | Sell |
24,516
-19,294
| -44% | -$370K | 0.03% | 644 |
|
|
2016
Q4 | $730K | Sell |
43,810
-2,235
| -5% | -$37.2K | 0.04% | 470 |
|
|
2016
Q3 | $948K | Sell |
46,045
-130,158
| -74% | -$2.68M | 0.04% | 507 |
|
|
2016
Q2 | $5.39M | Buy |
+176,203
| New | +$5.39M | 0.24% | 109 |
|